Search

everythinglearnresearchcommunity

for

Search:↓

Certain long non-coding RNAs in cashmere goats affect hair growth when treated with a specific growth factor.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

FFA and FAPD might be related or stages of the same disease.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

LONRF1 is important for oxidative damage response and tissue remodeling during wound healing.

FFA patients have fewer melanocytes and thinner skin compared to others.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

A new gene mutation causes vitamin D-resistant rickets and hair loss in two siblings.

RD26 controls root hair growth during drought by repressing key genes, helping plants save energy.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

FFA in men shows unique features and treatment results vary widely.

Methotrexate may help stabilize frontal fibrosing alopecia.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Mutations in the KRT85 gene cause hair and nail problems.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

FGF5 gene mutations cause long hair in domestic cats.

WNT activation in scalp fibroblasts boosts hair growth by increasing FGF9.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

The flaky skin mouse mutation is a natural model for studying human psoriasis.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia can occur in men and may be linked to immune triggers like vaccines.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.